Insights

Incorporating the patient voice from clinical development to commercialisation

Patients increasingly want to be more involved in their healthcare, decisions about it and research towards its improvement,

Incorporating the patient voice from clinical development to commercialisation

https://pharmaphorum.com/patients/incorporating-the-patient-voice-from-clinical-development-to-commercialisation/

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

https://pharmaphorum.com/debates-insight-patients/patient-centricity-identifying-boehringer-ingelheim-uk-can-better/

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

‘Patient-centricity’ is one of the buzzwords of the life sciences industry. It demonstrates a shift in the way

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

https://pharmaphorum.com/whitepapers/ideals-execution-reality-patient-centricity-2016-whats-next-pharma/

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

https://pharmaphorum.com/whitepapers/an-integrated-digital-ecosystem-to-support-patient-outcomes-health-system-sustainability-and-return-on-investment/

Patient centricity: How does Boehringer Ingelheim UK measure up?

Patient centricity is a subject that is massively talked about but few can ‘walk the talk’. Fewer still can demonstrate what

Patient centricity: How does Boehringer Ingelheim UK measure up?

https://pharmaphorum.com/whitepapers/patient-centricity-how-does-boehringer-ingelheim-uk-measure-up/

Patient centricity: What it means and why it’s important to have patients at the centre of our thinking

Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it

Patient centricity: What it means and why it’s important to have patients at the centre of our thinking

https://pharmaphorum.com/whitepapers/patient-centricity-what-it-means-and-why-it-s-important-to-have-patients-at-the-centre-of-our-thinking/

Improved health and wellbeing in COPD

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant

Improved health and wellbeing in COPD

https://pharmaphorum.com/whitepapers/improved-health-and-wellbeing-in-copd/

1 2 3

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Insights